Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)
China flag China · Delayed Price · Currency is CNY
2.100
+0.030 (1.45%)
Nov 20, 2024, 11:30 AM CST

Sichuan Hebang Biotechnology Corporation Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
9,0868,70712,9419,9285,2325,954
Upgrade
Other Revenue
117.15117.1597.7359.6629.1614.96
Upgrade
Revenue
9,2038,82413,0399,9875,2615,969
Upgrade
Revenue Growth (YoY)
2.49%-32.33%30.55%89.85%-11.87%-0.66%
Upgrade
Cost of Revenue
8,0216,8237,4925,8744,3454,745
Upgrade
Gross Profit
1,1822,0015,5474,113916.121,224
Upgrade
Selling, General & Admin
506.17456.82871.3344.56315.52484.25
Upgrade
Research & Development
41.2247.3567.9333.3139.6838.3
Upgrade
Other Operating Expenses
67.2260.72110.1789.143.945.42
Upgrade
Operating Expenses
616.49579.061,061462.95393.59581.26
Upgrade
Operating Income
565.371,4224,4863,651522.54643.23
Upgrade
Interest Expense
-42.74-24.37-51.43-77.82-82.16-57.04
Upgrade
Interest & Investment Income
76.13135.5744.5236.3128.046.91
Upgrade
Currency Exchange Gain (Loss)
-1.87-1.875.22-14.7-32.72-7.69
Upgrade
Other Non Operating Income (Expenses)
-16.85-10.11-1.55-14.91-9.52-4.67
Upgrade
EBT Excluding Unusual Items
580.051,5214,4823,579426.17580.74
Upgrade
Impairment of Goodwill
---66.07---
Upgrade
Gain (Loss) on Sale of Investments
-1.26-----1.23
Upgrade
Gain (Loss) on Sale of Assets
-0.220.6936.99-1.236.67-2.42
Upgrade
Other Unusual Items
13.5914.3925.310.2-417.036.67
Upgrade
Pretax Income
585.631,5364,4793,57815.81583.75
Upgrade
Income Tax Expense
125.47257.27668.32551.8812.977.14
Upgrade
Earnings From Continuing Operations
460.161,2793,8103,0272.91506.61
Upgrade
Minority Interest in Earnings
25.364.54-3.43-8.0338.0310.24
Upgrade
Net Income
485.521,2833,8073,01840.94516.85
Upgrade
Net Income to Common
485.521,2833,8073,01840.94516.85
Upgrade
Net Income Growth
-65.28%-66.29%26.12%7272.47%-92.08%42.35%
Upgrade
Shares Outstanding (Basic)
8,3568,7068,6978,4368,5308,658
Upgrade
Shares Outstanding (Diluted)
8,3568,7068,6978,4368,5308,658
Upgrade
Shares Change (YoY)
-4.23%0.10%3.10%-1.10%-1.48%-4.62%
Upgrade
EPS (Basic)
0.060.150.440.360.000.06
Upgrade
EPS (Diluted)
0.060.150.440.360.000.06
Upgrade
EPS Growth
-63.75%-66.32%22.33%7354.17%-91.96%49.25%
Upgrade
Free Cash Flow
-932.6-748.41,7081,462171.76-499.62
Upgrade
Free Cash Flow Per Share
-0.11-0.090.200.170.02-0.06
Upgrade
Dividend Per Share
0.020-0.0450.015--
Upgrade
Dividend Growth
-55.56%-200.00%---
Upgrade
Gross Margin
12.84%22.67%42.54%41.19%17.41%20.51%
Upgrade
Operating Margin
6.14%16.11%34.40%36.55%9.93%10.78%
Upgrade
Profit Margin
5.28%14.54%29.20%30.22%0.78%8.66%
Upgrade
Free Cash Flow Margin
-10.13%-8.48%13.10%14.64%3.26%-8.37%
Upgrade
EBITDA
1,6082,4105,4004,2821,1651,279
Upgrade
EBITDA Margin
17.48%27.31%41.42%42.87%22.15%21.42%
Upgrade
D&A For EBITDA
1,043987.99914.52631.02642.95635.6
Upgrade
EBIT
565.371,4224,4863,651522.54643.23
Upgrade
EBIT Margin
6.14%16.11%34.40%36.55%9.93%10.78%
Upgrade
Effective Tax Rate
21.42%16.75%14.92%15.42%81.60%13.21%
Upgrade
Revenue as Reported
9,2038,82413,0399,9875,2615,969
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.